11 reports of this reaction
1.4% of all ACETAMINOPHEN, DIPHENHYDRAMINE HCL reports
#17 most reported adverse reaction
ANAEMIA is the #17 most commonly reported adverse reaction for ACETAMINOPHEN, DIPHENHYDRAMINE HCL, manufactured by United Natural Foods, Inc. dba UNFI. There are 11 FDA adverse event reports linking ACETAMINOPHEN, DIPHENHYDRAMINE HCL to ANAEMIA. This represents approximately 1.4% of all 782 adverse event reports for this drug.
Patients taking ACETAMINOPHEN, DIPHENHYDRAMINE HCL who experience anaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANAEMIA is a less commonly reported adverse event for ACETAMINOPHEN, DIPHENHYDRAMINE HCL, but still significant enough to appear in the safety profile.
In addition to anaemia, the following adverse reactions have been reported for ACETAMINOPHEN, DIPHENHYDRAMINE HCL:
The following drugs have also been linked to anaemia in FDA adverse event reports:
ANAEMIA has been reported as an adverse event in 11 FDA reports for ACETAMINOPHEN, DIPHENHYDRAMINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANAEMIA accounts for approximately 1.4% of all adverse event reports for ACETAMINOPHEN, DIPHENHYDRAMINE HCL, making it a notable side effect.
If you experience anaemia while taking ACETAMINOPHEN, DIPHENHYDRAMINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.